Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Higher-dose oxytocin and hemorrhage after vaginal delivery: a randomized controlled trial.

Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A, Figueroa D, Quinn R, Andrews WW, Hauth JC.

Obstet Gynecol. 2012 Feb;119(2 Pt 1):293-300. doi: 10.1097/AOG.0b013e318242da74.

2.

Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.

Borruto F, Treisser A, Comparetto C.

Arch Gynecol Obstet. 2009 Nov;280(5):707-12. doi: 10.1007/s00404-009-0973-8. Epub 2009 Feb 20.

PMID:
19229549
3.

Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.

Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, Bussieres L, Aegerter P, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie (GROG).

Obstet Gynecol. 2016 Oct;128(4):805-11. doi: 10.1097/AOG.0000000000001626.

PMID:
27607864
4.

Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.

Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT.

Am J Obstet Gynecol. 2013 Jul;209(1):51.e1-6. doi: 10.1016/j.ajog.2013.03.011. Epub 2013 Mar 15.

5.

Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.

King KJ, Douglas MJ, Unger W, Wong A, King RA.

Anesth Analg. 2010 Dec;111(6):1460-6. doi: 10.1213/ANE.0b013e3181f8930a. Epub 2010 Oct 1.

PMID:
20889945
6.

Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.

Pantoja T, Abalos E, Chapman E, Vera C, Serrano VP.

Cochrane Database Syst Rev. 2016 Apr 14;4:CD011491. doi: 10.1002/14651858.CD011491.pub2. Review.

PMID:
27078125
7.

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.

Westhoff G, Cotter AM, Tolosa JE.

Cochrane Database Syst Rev. 2013 Oct 30;(10):CD001808. doi: 10.1002/14651858.CD001808.pub2. Review.

PMID:
24173606
8.

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.

Chaudhuri P, Biswas J, Mandal A.

Int J Gynaecol Obstet. 2012 Feb;116(2):138-42. doi: 10.1016/j.ijgo.2011.09.016. Epub 2011 Nov 17.

PMID:
22100204
9.

Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.

George RB, McKeen D, Chaplin AC, McLeod L.

Can J Anaesth. 2010 Jun;57(6):578-82. doi: 10.1007/s12630-010-9297-1. Epub 2010 Mar 18.

PMID:
20238255
10.

Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Int J Gynaecol Obstet. 2016 Sep;134(3):324-8. doi: 10.1016/j.ijgo.2016.01.025. Epub 2016 May 25.

PMID:
27350226
11.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005457. doi: 10.1002/14651858.CD005457.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;(4):CD005457.

PMID:
22336812
12.
13.

Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.

Badejoko OO, Ijarotimi AO, Awowole IO, Loto OM, Badejoko BO, Olaiya DS, Fatusi AO, Kuti O, Orji EO, Ogunniyi SO.

J Obstet Gynaecol Res. 2012 Nov;38(11):1294-301. doi: 10.1111/j.1447-0756.2012.01869.x. Epub 2012 May 21.

PMID:
22612662
14.

Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial.

Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks White RE, Varin J.

J Obstet Gynaecol Can. 2004 May;26(5):481-8.

PMID:
15151735
15.

Carbetocin for preventing postpartum haemorrhage.

Su LL, Chong YS, Samuel M.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005457. doi: 10.1002/14651858.CD005457.pub4. Review.

PMID:
22513931
16.

A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.

Chaudhuri P, Majumdar A.

Int J Gynaecol Obstet. 2016 Feb;132(2):191-5. doi: 10.1016/j.ijgo.2015.06.064. Epub 2015 Nov 6.

PMID:
26613819
17.

Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.

Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, Dao B, Durocher J, Yalvac S, Diop A, Dzuba IG, Ngoc NT.

Lancet. 2010 Jan 16;375(9710):217-23. doi: 10.1016/S0140-6736(09)61923-1. Epub 2010 Jan 6.

PMID:
20060162
18.

Misoprostol versus oxytocin for the reduction of postpartum blood loss.

Baskett TF, Persad VL, Clough HJ, Young DC.

Int J Gynaecol Obstet. 2007 Apr;97(1):2-5. Epub 2007 Feb 26.

PMID:
17321529
19.

Higher-dose oxytocin to prevent obstetric hemorrhage at vaginal delivery-does duration of infusion matter?

Subramaniam A, Abramovici AR, Szychowski JM, Roach M, Owen J, Biggio JR, Tita AT.

Am J Perinatol. 2014 Nov;31(11):1003-8. doi: 10.1055/s-0034-1370347. Epub 2014 Feb 28.

PMID:
24585000
20.

Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.

Hernández-Castro F, López-Serna N, Treviño-Salinas EM, Soria-López JA, Sordia-Hernández LH, Cárdenas-Estrada E.

Int J Gynaecol Obstet. 2016 Feb;132(2):184-7. doi: 10.1016/j.ijgo.2015.06.060. Epub 2015 Oct 23.

PMID:
26534874

Supplemental Content

Support Center